Uttranchal Pharmaceuticals Private Limited

Uttranchal Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2005PTC138489 Incorporated 08 July 2005 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹4.94 Cr
▲ 2% YoY
Net profit · FY 2025
₹5.29 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹45.64 Lakh
EBITDA margin 9.2%
Authorised capital
₹2.15 Cr
Registered with MCA
Paid-up capital
₹2.15 Cr
Issued & subscribed
Open charges
₹8.35 Cr
Satisfied ₹5.05 Cr
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings

About Uttranchal Pharmaceuticals Private Limited

Data last updated:

Uttranchal Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 July 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC138489. Its GSTIN is 05AAACU8590L1ZU (Uttarakhand).

The company has an authorised share capital of ₹2.15 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors Kathiravanathan (Managing Director) and Nitha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.94 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹5.29 Lakh (net margin 1.1%) and EBITDA of ₹45.64 Lakh (EBITDA margin 9.2%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 12% over five years.

As per MCA filings, the company has open charges of ₹8.35 Cr and satisfied charges of ₹5.05 Cr on record. Court records list 1 case involving the company, including 1 filed against it.

Uttranchal Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0003408). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232DL2005PTC138489
Registration Number 138489
Incorporation Date 08 July 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-06-0003408

Recognitions & Rankings of Uttranchal Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-UK-06-0003408

Contact details

Uttranchal Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    B – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Uttranchal Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Uttranchal Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Financials of Uttranchal Pharmaceuticals Private Limited

FY 2025 filings available

Uttranchal Pharmaceuticals Private Limited reported revenue of ₹4.94 Cr (up 2% YoY) for FY 2025.

Revenue · FY 2025
₹4.94 Cr ▲ 2%
Net profit · FY 2025
₹5.29 Lakh margin 1.1%
EBITDA · FY 2025
₹45.64 Lakh margin 9.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 21%
5 years · compounded
▲ 12%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 33%
5 years · compounded
▲ 20%

Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 2% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹45.64 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.29 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.2%
Net Profit Margin1.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Board of directors of Uttranchal Pharmaceuticals Private Limited

Uttranchal Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
KathiravanathanManaging Director20 Jan 201511 Years 9 MonthsCurrent
NithaDirector20 Jan 201511 Years 9 MonthsCurrent

Peer comparison

Uttranchal Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
NRJ Pharmachem Private Limited₹4.95 Cr (FY 2025)47.0%Navi Mumbai, Maharashtra, India
Elikem Nutra Private Limited₹4.95 Cr (FY 2025)92.0%Rakanpur, Gujarat, India
Uttranchal Pharmaceuticals Private Limitedthis company₹4.94 Cr (FY 2025)₹5.29 Lakh1.1%2.0%New Delhi, Delhi, India
Lewis Bioserch Pharma Private Limited₹4.94 Cr (FY 2024)19.0%Chandigarh, India
Cataliq Laboratories Private Limited₹4.94 Cr (FY 2024)-12.0%Ahmedabad, Gujarat, India
Karlin Pharmaceuticals & Exports Private Limited₹4.93 Cr (FY 2025)12.0%Chennai, Tamil Nadu, India

To see the full peer comparison of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Auditor

Uttranchal Pharmaceuticals Private Limited is audited by SINGH AMIT & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
SINGH AMIT & ASSOCIATESFY 2024019157C

Shareholding

The shareholding of Uttranchal Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2017FY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.35 Cr
Satisfied charges
₹5.05 Cr
Breakdown by lending institutions
Others₹8.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
28 May 2025101112591Others₹8.35 CrOpen
27 May 2023100730026Axis Bank Limited₹2.7 CrSatisfied
17 May 2022100576801Hdfc Bank Limited₹1.42 CrSatisfied
16 Jun 2020100360681Others₹13.12 LakhSatisfied
15 Apr 201510568692Punjab National Bank₹80 LakhSatisfied

To see the full charge records of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Uttranchal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Uttranchal Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
05AAACU8590L1ZUUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Uttranchal Pharmaceuticals Private Limited, buy the company report.

Recent activity

Uttranchal Pharmaceuticals Private Limited has 6 board changes on record since 2015: 2 appointments and 4 cessations. The latest: Suresh Kumar Khurana ceased to be Director on 24 Feb 2015.

AGM
Uttranchal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 27 May 2023 via Charge ID 100730026 with Axis Bank Limited was fully satisfied on 12 Jun 2025.
Charges
A charge with Others amounted to Rs. 8.35 Cr with Charge ID 101112591 was registered on 28 May 2025.
Filing
Uttranchal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 17 May 2022 via Charge ID 100576801 with Hdfc Bank Limited was fully satisfied on 15 Jun 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100730026 was registered on 27 May 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.42 Cr with Charge ID 100576801 was registered on 17 May 2022.
Charges
A charge registered on 16 Jun 2020 via Charge ID 100360681 with Others was fully satisfied on 11 May 2022.
Charges
A charge registered on 15 Apr 2015 via Charge ID 10568692 with Punjab National Bank was fully satisfied on 11 May 2022.
Charges
A charge with Others amounted to Rs. 0.13 Cr with Charge ID 100360681 was registered on 16 Jun 2020.
Charges
A charge with Punjab National Bank amounted to Rs. 0.80 Cr with Charge ID 10568692 was registered on 15 Apr 2015.
Ceased
Suresh Kumar Khurana ceased to be Director.

6 earlier events are in the company report.

Frequently asked questions

Uttranchal Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 July 2005 (21+ years old) and is registered under CIN U24232DL2005PTC138489.

Uttranchal Pharmaceuticals has 2 current directors:

The latest financial statements of Uttranchal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Uttranchal Pharmaceuticals is 05AAACU8590L1ZU, registered in Uttarakhand.

The CIN (Corporate Identification Number) of Uttranchal Pharmaceuticals is U24232DL2005PTC138489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Uttranchal Pharmaceuticals has 1 court case on record: 1 filed against it.

Uttranchal Pharmaceuticals was incorporated on 08 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Uttranchal Pharmaceuticals by revenue are NRJ Pharmachem Private Limited, Elikem Nutra Private Limited, Lewis Bioserch Pharma Private Limited, Cataliq Laboratories Private Limited, Karlin Pharmaceuticals & Exports Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Suresh Kumar Khurana ceased to be Director on 24 Feb 2015. Harish Nangia ceased to be Director on 09 Feb 2015. Krishan Kumar Nangia ceased to be Director on 09 Feb 2015. Uttranchal Pharmaceuticals has 6 board changes on record in total.

Yes, Uttranchal Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-06-0003408).

The registered office of Uttranchal Pharmaceuticals is at B – 737 Gali No.24 Sant Nagar Burari, New Delhi, Delhi, India – 110084.